Skip to main content

Primer on the Autonomic Nervous System

  • 4th Edition - December 7, 2022
  • Latest edition
  • Editors: Italo Biaggioni, Kirsteen Browning, Gregory Fink, Jens Jordan, Phillip A. Low, Julian F.R. Paton
  • Language: English

Primer on the Autonomic Nervous System, Fourth Edition provides a concise and accessible overview of autonomic neuroscience for students, scientists, and clinic… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Primer on the Autonomic Nervous System, Fourth Edition provides a concise and accessible overview of autonomic neuroscience for students, scientists, and clinicians. The book's 142 chapters draw on the expertise of more than 215 basic scientists and clinicians who discuss key information on how the autonomic nervous system controls the body, particularly in response to stress. This new edition also focuses on the translational crossover between basic and clinical research. In addition to comprehensively covering all aspects of autonomic physiology and pathology, topics such as psychopharmacology decoding and modulating nerve function are also explored.

Key features

  • Provides concise and practical information on the autonomic nervous system
  • Discusses all aspects of autonomic physiology and pathology
  • Contains new content on psychopharmacology and modulating nerve function

Readership

Researchers, clinical practitioners, medical and graduate students in neuroscience and neurology. Researchers and practitioners in cardiology, physiology, and hypertension

Table of contents

I. Introduction

1. Evolution of the Cardiovascular Autonomic Nervous System in Vertebrates

2. Central Autonomic Control

3. Peripheral Autonomic Nervous System

II. Biochemical and Pharmacological Mechanisms



4. Noradrenergic Neurotransmission

5. Antidepressant-Sensitive Norepinephrine Transporters: Structure and Regulation

6. a1-Adrenergic Receptors

7. Alpha2-Adrenergic Receptors

8. b-Adrenergic Receptors

9. Dopaminergic Neurotransmission

10. Dopamine Receptors

11. Cholinergic Neurotransmission

12. Acetylcholine and Muscarinic Receptors

13. Nicotinic Acetylcholine Receptors in the Autonomic Nervous System

14. Neuropeptide Y and the autonomic nervous system

15. Serotonin Receptors

16. Purinergic Neurotransmission and Nucleotide Receptors

17. Nitric Oxide and The Autonomic Nervous System

18. Glutamatergic Neurotransmission

19. Pharmacology: GABAergic Neurotransmission

20. Renin-Angiotensin

21. Aldosterone, the Mineralocorticoid Receptor and Sympathetic Nervous System

22. Vasopressin in central autonomic regulation

23. Calcitonin Gene-Related Peptide and Adrenomedullin

24. Leptin Signaling and Energy Homeostasis

25. The Endothelin System

26. Pharmacology of the neurotransmission of the baro- and chemoreflex in the Nucleus Tractus Solitarius

III. Autonomic Physiology



27. Rhythms in Sympathetic Nerve Activity

28. Circadian Rhythms and Autonomic Function

29. Cardiorespiratory interactions in health and disease

30. Baroreceptor reflexes

31. Cardiac and Other Visceral Afferents

32. Sympathetic control of the Heart

33. Cardiac Vagal Ganglia

34. Physiology of Upright Posture

35. Cerebral Circulation

36. Autonomic Control of the Pupil

37. Gastrointestinal Function

38. Extrinsic Control of Gastrointestinal Function

39. The Splanchnic Circulation

40. Autonomic Control of the Kidney

41. Autonomic Control of the Lower Urinary Tract

42. Bladder Function in Health and Disease

43. Physiology and Pathophysiology of Female Sexual Function

44. Sweating

45. Autonomic Innervation of the Skeleton

46. Regulation of Metabolism by the Autonomic Nervous System

47. Sex Differences in Autonomic Function

48. Autonomic Control During Pregnancy

49. Ageing and the autonomic nervous system

50. Autonomic Function in Sleep and Sleep Deprivation

51. Telemetric autonomic monitoring

IV. Autonomic Response to Environmental Challenges



52. Exercise

53. Psychological Stress and Autonomic Nervous System

54. Hypoglycemia

55. Autonomic Response to Hypovolemic Shock

56. Physiology of thermoregulation: central and peripheral mechanisms

57. Effects of High Altitude

58. Space Physiology

59. Noise, air pollution, and the autonomic nervous system

V. Pathophysiological Mechanisms



60. The autonomic inflammatory reflex

61. Reactive Oxygen Species and Oxidative Stress.

62. Insulin Resistance and the autonomic nervous System

63. Salt Sensitivity of Blood Pressure

64. Airway Afferent Nerves

VI. Evaluation of Autonomic Function



65. Clinical Evaluation of Autonomic Disorders

66. Autonomic Function Testing

67. Tilt Table Testing

68. Patient Symptom and Rating Scales: OHQ, COMPASS, UMSARS

69. Sympathetic Microneurography and clinical applications

70. Assessment of the Autonomic Control of the Cardiovascular System by a Frequency Domain Approach

71. Assessment of Sudomotor Function

72. Plasma Catechols

73. Imaging cortical and subcortical sites involved in cardiovascular control

74. Clinical sympathetic Imaging

75. Cutaneous Autonomic Innervation: Assessment by Skin Biopsy

76. Sympatho-effector transduction

VII. Cardiovascular Disorders



77. Neurally (Autonomically) Mediated Syncope

78. Orthostatic Hypotension

79. Spectrum of orthostatic hypotension

80. Baroreflex Failure

81. Essential Hypertension

82. Obesity-Associated hypertension

83. Pheochromocytoma and paraganglioma

84. Autonomic Dysfunction in Heart Failure

85. Myocardial stunning and Takotsubo Cardiomyopathy

86. The Autonomic Nervous System and Cardiac Arrhythmias

VIII. Congenital Autonomic Disorders



87. Deficiencies of Tetrahydrobiopterin, Tyrosine Hydroxylase and Aromatic L-Amino Acid Decarboxylase

88. Congenital disorders of noradrenergic neurotransmission

89. Monoamine Oxidase Deficiency

90. Congenital Central Hypoventilation Syndrome (CCHS) and PHOX2B Pathogenic Variants

91. Hereditary Autonomic Neuropathies

92. Familial Dysautonomia (Riley-Day Syndrome)

IX. Autonomic Synucleinopathies



93. a-Synuclein and Neurodegeneration

94. Multiple System Atrophy

95. Parkinson’s Disease

96. Dementia with Lewy Bodies

97. Pure Autonomic Failure

X. Peripheral Autonomic Disorders



98. Small Fiber Neuropathy

99. Diabetic Autonomic Dysfunction

100. Amyloidosis and Autonomic Failure

101. Autoimmune Autonomic Syndromes

102. Paraneoplastic Autonomic Dysfunction

103. Autonomic Disturbances Following Spinal Cord Injury

104. Drug-Induced Autonomic Dysfunction

XI. Autonomic Syndromes



105. Postural Tachycardia Syndrome. Pathophysiological Mechanisms

106. Postural Tachycardia Syndrome (POTS)

107. Joint Hypermobility and Dysautonomia

108. Mast Cell Activation and Autonomic Disorders

109. Chronic Fatigue Syndrome and the Autonomic Nervous System

XII. Special Clinical Conditions



110. Neuroleptic Malignant Syndrome

111. Migraine and the Autonomic Nervous System

112. Autonomic Regulation in Epilepsy

113. Autonomic complications of acute brain injury and stroke

114. Sleep Apnea

115. Panic Disorder

116. Disorders of Sweating

117. Complex Regional Pain Syndrome

118. Abdominal Pain and Cyclic Vomiting

119. Male Erectile Dysfunction

XIII. Management of Neurogenic Orthostatic Hypotension



120. Management of Orthostatic Hypotension - Introduction

121. Physical Measures

122. Dietary Sodium and Fludrocortisone

123. Water and the Osmopressor Response

124. Midodrine

125. Droxidopa

126. Pyridostigmine in Autonomic Disorders

127. Norepinephrine Transporter Inhibitors in Autonomic Disorders

128. Acarbose and octreotide for the treatment of postprandial hypotension

129. Management of Supine Hypertension of Autonomic Failure

130. Anesthetic considerations in patients with autonomic dysfunction

131. Chronic constitutional hypotension

XIV. Autonomic Neuromodulation as a Treatment Strategy



132. Renal Denervation as Therapeutic Intervention

133. Baroreflex amplification by carotid sinus stimulation

134. Targeting Carotid Body Chemoreceptors as a therapeutic intervention

135. Bionic Baroreflex

136. Therapeutic targeting of splanchnic nerves

XV. Novel Approaches in Autonomic Neuroscience



137. Modeling the Autonomic Nervous System

138. Optogenetics: Application to central autonomic regulatory pathways

139. Mapping the Autonomic Nervous System: The SPARC project

140. Autonomic Nervous System-Gut-Microbiome Axis in Chronic Diseases

141. Novel Fluid Biomarkers in Synucleinopathies

142. Novel Disease-Modifying Treatments for Synucleinopathies

Review quotes

*4 stars* “...an updated, inclusive, and accessible overview of the autonomic nervous system in health and disease while offering key references for more in-depth information…. [Its] comprehensive nature makes the book suitable as a text for students learning about the autonomic nervous system or a reference for practitioners of science and medicine looking for continued education or a refresher on workup and management of specific diseases…. Each chapter is structured like a mini review article, complete with color figures and tables that summarize key content and a reference section for suggested further reading…. [A] concise yet comprehensive guide for anyone with a biology background interested in learning more about the autonomic nervous system.” —©Doody’s Review Service, 2023, Heping Sheng, MD (Thomas Jefferson University)

Product details

  • Edition: 4
  • Latest edition
  • Published: December 9, 2022
  • Language: English

About the editors

IB

Italo Biaggioni

Dr. Biaggioni has almost 40 years’ experience investigating the interaction between neural (autonomic) metabolic (renin- angiotensin, insulin) and local (adenosine, nitric oxide) factors involved in cardiovascular regulation. He has had continued NIH funding that has resulted in over 330 peer-reviewed publications. Dr. Biaggioni directs the Vanderbilt Autonomic Dysfunction Center, a multidisciplinary program dedicated to applying clinical research to development novel treatment strategies. His group has discovered 4 novel congenital autonomic disorders and has participated in the development of new medications, have repurposed many approved drugs, and developed novel devices.
Affiliations and expertise
Director, Vanderbilt Autonomic Dysfunction Center; David Robertson Professor of Autonomic Disorders, Professor of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN, United States

KB

Kirsteen Browning

Dr. Kirsteen Browning is a Professor of Neural and Behavioral Science at Penn State University. She is also Associate Director of the MD/PhD Medical Scientist Training Program. Her research interest is in the regulation of gastrointestinal vagal neurocircuits and vagally mediated peripheral sensation and signaling.
Affiliations and expertise
Professor of Neural and Behavioral Science and Associate Director, MD/PhD Medical Scientist Training Program, Penn State University College of Medicine, Hershey, PA, United States

GF

Gregory Fink

Dr. Gregory Fink is a Professor in Pharmacology and Toxicology at Michigan State University. His research continues to concern central and peripheral mechanisms of blood pressure regulation in hypertension, but other important interests are the renin-angiotensin system, endothelin and the role of venous function and body fluid volume distribution in control of blood pressure. Fink has served on the executive committee and as treasurer for the Inter-American Society of Hypertension, as chairman of the National Institutes of Health, or NIH , Experimental Cardiovascular Sciences Study Section and he just recently finished a two-year term as chair of the American Heart Association Council on Hypertension.
Affiliations and expertise
Professor in Pharmacology and Toxicology, Michigan State University, East Lansing, MI, United States

JJ

Jens Jordan

Jens Jordan is Head of the Institute of Aerospace Medicine at the German Aerospace Center and the University of Cologne in Germany. Previously, he directed the Institute for Clinical pharmacology at Hannover Medical School. His group pursues cardiovascular control mechanisms and molecular mechanisms responsible for premature cardiovascular and metabolic disease in human beings. The overall goal is to find ways of extending the healthy lifespan on earth and in space.
Affiliations and expertise
Head of the Institute of Aerospace Medicine, German Aerospace Center and University of Cologne, Cologne, Germany

PL

Phillip A. Low

Dr. Phillip Low is a Neurologist at the Mayo Clinic focusing on Autonomic Disorders. Phillip A. Low, M.D. has a long-standing research focus on clinical and laboratory research into the cause and treatment of autonomic disorders. Efforts have been concentrated on following major areas: multiple system atrophy; development of novel biomarkers and tests and instruments to study autonomic disorders; diagnosis and treatment of autonomic neuropathies; conducting randomized clinical trials. Dr. Low's research has been continuously funded by the National Institutes of Health (NIH) for over the past 30 years.
Affiliations and expertise
Neurologist at the Mayo Clinic focusing on Autonomic Neuropathy

JP

Julian F.R. Paton

Professor Paton is the Director of Manaaki Manawa – the Centre for Heart Research in Auckland. Through modulation of the autonomic nervous system, his research aims to inform new potential ways to control blood pressure in the condition of hypertension and to alleviate heart failure and sleep apnoea. He uses an inter-disciplinary approach involving mathematical modelling, pre-clinical and first-in-human studies incorporating novel drugs and device based therapeutic strategies.
Affiliations and expertise
Professor of Translational Physiology, Manaaki Manawa – The Centre for Heart Research, Department of Physiology, University of Auckland, Auckland, New Zealand

View book on ScienceDirect

Read Primer on the Autonomic Nervous System on ScienceDirect